Literature DB >> 9796992

Expression of mouse mammary tumor virus-like env gene sequences in human breast cancer.

Y Wang1, V Go, J F Holland, S M Melana, B G Pogo.   

Abstract

We have reported previously (Wang et al, Cancer Res., 55: 5173-5179, 1995) the presence of a 660-bp sequence that is 90-98% homologous to the env gene of mouse mammary tumor virus in 38% of 314 unselected breast cancer samples, in some breast cancer cell lines, and in 1.8% of the 107 normal breast specimens from reduction mammoplasties. In this communication, we have investigated whether the 660-bp sequence or a smaller 256-bp sequence within the 660 bp were expressed in breast tumors, normal breasts, and breast cancer cell lines by means of reverse transcription-PCR. The results indicated that expression of the 660-bp sequence was detected in 66% of the sequence-positive breast tumors studied and in none of the negative tumors or normal breasts and that the 256-bp sequence was expressed in all of the env-positive breast cancer cell lines tested. Sequence analysis revealed that the expressed 660-bp sequence is 98% homologous to the env gene of mouse mammary tumor virus with only one small stretch of 46 bp homologous to endogenous viral sequences. The presence and expression of this sequence is related to a group of human breast cancers in which the concept of a retroviral etiology can be entertained.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9796992

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  15 in total

Review 1.  Infection, stem cells and cancer signals.

Authors:  S Sell
Journal:  Curr Pharm Biotechnol       Date:  2011-02-01       Impact factor: 2.837

2.  Presence of mouse mammary tumor virus specifically alters the body odor of mice.

Authors:  Kunio Yamazaki; Edward A Boyse; Judith Bard; Maryanne Curran; David Kim; Susan R Ross; Gary K Beauchamp
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

3.  High prevalence of MMTV-like env gene sequences in gestational breast cancer.

Authors:  Y Wang; S M Melana; B Baker; I Bleiweiss; M Fernandez-Cobo; J F Mandeli; J F Holland; B G T Pogo
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

Review 4.  Common integration sites for MMTV in viral induced mouse mammary tumors.

Authors:  Robert Callahan; Gilbert H Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-08-15       Impact factor: 2.673

5.  Variable transcriptional activity of endogenous retroviruses in human breast cancer.

Authors:  Oliver Frank; Caroline Verbeke; Norbert Schwarz; Jens Mayer; Alice Fabarius; Rüdiger Hehlmann; Christine Leib-Mösch; Wolfgang Seifarth
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

Review 6.  The possible involvement of virus in breast cancer.

Authors:  Marla Karine Amarante; Maria Angelica Ehara Watanabe
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-14       Impact factor: 4.553

7.  Transcription profile of a human breast cancer cell line expressing MMTV-like sequences.

Authors:  Mariana Fernandez-Cobo; Stella M Melana; James F Holland; Beatriz G T Pogo
Journal:  Infect Agent Cancer       Date:  2006-12-15       Impact factor: 2.965

Review 8.  From Bittner to Barr: a viral, diet and hormone breast cancer aetiology hypothesis.

Authors:  J S Lawson; D Tran; W D Rawlinson
Journal:  Breast Cancer Res       Date:  2000-12-18       Impact factor: 6.466

9.  Does a betaretrovirus infection trigger primary biliary cirrhosis?

Authors:  Lizhe Xu; Zhiwei Shen; Linsheng Guo; Brent Fodera; Adrian Keogh; Ruth Joplin; Barbara O'Donnell; James Aitken; William Carman; James Neuberger; Andrew Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 12.779

Review 10.  Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease.

Authors:  Cécile Voisset; Robin A Weiss; David J Griffiths
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 13.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.